Pneumonia

 
Study Finds Persistent Racial/Ethnic, Socioeconomic Disparities in Adult Vaccination Coverage 2010 - 2019
July 30, 2021

Rates of routine ACIP-recommended vaccination have been persistently and significantly lower among racial and ethnic minorities over the past decade, according to new research.

6 New Drugs Approved for Primary Care: Q2 2021
July 08, 2021

From obesity to pneumococcal disease, we have picked the top 6 FDA-approved drugs every primary care physician should know about from the second quarter.

FDA-approved: Pneumococcal 20-Valent Conjugate Vaccine for Adults
June 11, 2021

The vaccine is indicated for prevention of invasive disease and pneumonia caused by 20 Streptococcus pneumoniae serotypes.

ACP Guidance on Antibiotic Use: 4 Conditions Ideal for Short-course Treatment
April 06, 2021

Longer antibiotic treatment courses can often be safely and effectively shortened, according to the ACP guidance; 4 common conditions serve as examples.

Routine Adult Vaccination Rates Still Low: Slow Post-lockdown Rebound
March 05, 2021

Routine adult vaccination rates have yet to reach pre-pandemic levels, according to a report in MMWR this week. Which vaccines are most affected and which groups are lagging?

ACIP 2021 Adult Immunization Schedule Changes: A Quick Take
February 26, 2021

Review changes to the CDC Advisory Committee on Immunization Practices' 2021 recommended vaccination schedule for adults with this short slide-show review.

Influenza, Pneumococcal Disease, and COVID-19: What do Americans Think?
October 14, 2020

A new survey from the National Foundation for Infectious Diseases found key insights into what Americans believe about flu, pneumococcal disease, and COVID-19.

USPSTF (Still) Recommends Against Screening for COPD
September 01, 2015

Once again, the USPSTF finds no net benefit to screening asymptomatic persons for COPD. Draft recommendation is available for comment.

Corticosteroids Improved Outcomes, Recovery from Community Acquired Pneumonia
September 01, 2015

Reductions in mortality, need for life support, hospital stays, and other measures should win this drug class serious consideration, study authors say.

Risk Factors Identified for 30-day Mortality in Patients with Pneumonia
August 11, 2015

Targeting these risk factors with adjunctive therapy may help improve outcomes, say authors of a new study.